Reported results
- Collaboration revenues were $0 for the third quarter of 2026 compared to $2.8 million for the third quarter of 2025.
- Research and development expenses were $128.5 million for the third quarter of 2026 compared to $74.1 million for the third quarter of 2025.
- General and administrative expenses were $18.7 million for the third quarter of 2026 compared to $17.3 million for the third quarter of 2025.
- Net loss was $132.0 million for the third quarter of 2026 compared to $82.2 million for the third quarter of 2025.
- Cash, cash equivalents and investments were $1.6 billion as of September 30, 2026.
Guidance
- The Company does not expect to recognize additional collaboration revenue in 2026.
- The Company expects that its cash balance will provide the Company with a cash runway into 2029.
Price and volatility reaction
The stock moved +0.1% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -6.5 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 122.51 | 2026-10-28 |
| Close after release | 122.6 | 2026-10-29 |
| Realised move | +0.1% | close to close |
| 30d ATM IV change | -6.5 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.
